HOOKIPA Pharma Inc HOOK:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
0.94quote price arrow up+0.0148 (+1.5911%)
Volume
5,756
Close
0.9302quote price arrow up+0.0123 (+1.34%)
Volume
304,480
52 week range
0.41 - 2.05
Loading...
  • Open0.94
  • Day High0.9486
  • Day Low0.91
  • Prev Close0.9179
  • 52 Week High2.05
  • 52 Week High Date05/12/23
  • 52 Week Low0.41
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap89.811M
  • Shares Out96.55M
  • 10 Day Average Volume2.11M
  • Dividend-
  • Dividend Yield-
  • Beta0.77
  • YTD % Change14.84

KEY STATS

  • Open0.94
  • Day High0.9486
  • Day Low0.91
  • Prev Close0.9179
  • 52 Week High2.05
  • 52 Week High Date05/12/23
  • 52 Week Low0.41
  • 52 Week Low Date10/26/23
  • Market Cap89.811M
  • Shares Out96.55M
  • 10 Day Average Volume2.11M
  • Dividend-
  • Dividend Yield-
  • Beta0.77
  • YTD % Change14.84

RATIOS/PROFITABILITY

  • EPS (TTM)-0.98
  • P/E (TTM)-0.95
  • Fwd P/E (NTM)-2.56
  • EBITDA (TTM)-81.376M
  • ROE (TTM)-84.81%
  • Revenue (TTM)20.129M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-405.29%
  • Debt To Equity (MRQ)1.25%

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On HOOKIPA Pharma Inc

 

Profile

MORE
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include...
Jan Van De Winkel Ph.D.
Independent Chairman of the Board
Joern Aldag
Chief Executive Officer, Director
Roman Necina Ph.D.
Chief Operating Officer
Reinhard Kandera
Chief Financial Officer, Director
Address
350 Fifth Avenue, 72Nd Floor, Suite 7240
New York, NY
10118
United States

Top Peers

SYMBOLLASTCHG%CHG
GRTS
Gritstone bio Inc
0.9627+0.0927+10.6552%
CARM
Carisma Therapeutics Inc
1.62+0.02+1.25%
CRIS
Curis Inc
16.36-0.15-0.91%
OCUP
Ocuphire Pharma Inc
1.99+0.14+7.57%
ACRS
Aclaris Therapeutics Inc
1.36+0.05+3.82%